Work

The C5a complement activation peptide increases IL-1β and IL-6 release from amyloid-β primed human monocytes: implications for Alzheimer’s disease

Year: 2000

Type: article

Source: Journal of Neuroimmunology

DOI: 10.1016/s0165-5728(00)00291-5

Authors: Stephen O’Barr, Neil R Cooper

Institutions: Western University of Health Sciences, Scripps Research Institute

Language: English

Topic: Neuroinflammation and Neurodegeneration Mechanisms

Subfield: Neurology

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke

Awards: Aging Disease--Prion/Transgenic/Immunologic Studies, G3734952186, G415628284, ROLE OF COMPLEMENT ACTIVATION IN ALZHEIMER'S DISEASE, Blood System in Coagulation and Vessel Disease, G780887005

OpenAlex ID: W2088721908

FWCI: 2.472

Cites: 54

Cited by: 63

Related to: 10